Medicare Enrolled
Dr. Amy Law, M.D.
Hematology & Oncology · Rancho Mirage, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Law from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Law?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Law
Dr. Amy Law is a hematology & oncology specialist in Rancho Mirage, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Law performed 368,240 Medicare services across 6,686 unique beneficiaries.
Between the years covered by Open Payments, Dr. Law received a total of $26,394 from 111 pharmaceutical and/or device companies across 1407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Law is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$26,394 industry payments
Medicare Practice Summary
Medicare Utilization ↗368,240
Medicare services
Top 1% in CA for hematology & oncology
6,686
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18,412 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
145,500 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 34,680 | $18 | $58 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
25,500 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 24,200 | $43 | $137 |
| Nivolumab injection (Opdivo) | 23,300 | $24 | $77 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
19,950 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
14,240 | $6 | $21 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
12,670 | $36 | $118 |
| Paclitaxel chemotherapy injection | 10,119 | $0 | $0 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 7,800 | $0 | $0 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
7,010 | $23 | $143 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,224 | $0 | $0 |
| Trastuzumab biosimilar injection, 10 mg An injection of trastuzumab-qyyp, a biosimilar medication, administered in a 10 mg dose. |
4,514 | $21 | $170 |
| Injection, granisetron hydrochloride, 100 mcg | 3,180 | $0 | $1 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,170 | $22 | $161 |
| Injection, fulvestrant, 25 mg | 2,520 | $8 | $108 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,518 | $8 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,080 | $1 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,816 | $13 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,813 | $8 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,684 | $102 | $337 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
1,500 | $31 | $108 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,315 | $10 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,281 | $12 | $37 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
1,031 | $11 | $36 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
979 | $113 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
919 | $70 | $238 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
701 | $54 | $194 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
606 | $0 | $2 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
418 | $1 | $3 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
350 | $2 | $6 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 348 | $3 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
338 | $144 | $470 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
336 | $90 | $842 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
317 | $24 | $82 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
310 | $2 | $10 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
295 | $17 | $58 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
289 | $1 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
275 | $27 | $95 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
268 | $25 | $84 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
267 | $3 | $11 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
260 | $1 | $5 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
256 | $6 | $28 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
251 | $29 | $88 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
237 | $1 | $20 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
221 | $56 | $189 |
| New patient office visit, complex (60-74 min) | 188 | $166 | $573 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
158 | $62 | $217 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
140 | $6 | $15 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
134 | $7 | $20 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
133 | $98 | $294 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
132 | $1 | $2 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
81 | $56 | $141 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
75 | $48 | $163 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
73 | $8 | $45 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
67 | $74 | $286 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
56 | $32 | $110 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
45 | $21 | $76 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $119 | $434 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $144 | $518 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $66 | $192 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $48 | $147 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $58 | $238 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.0% high complexity
53.0% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$26,394
Total received (2018-2024)
Avg $3,771/year across 7 years
Top 17% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
111
Companies
1,407
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,158 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$236 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,271
2023
$4,789
2022
$4,511
2021
$3,902
2020
$2,836
2019
$3,399
2018
$2,686
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$336
PFIZER INC.
$325
Novartis Pharmaceuticals Corporation
$308
Janssen Biotech, Inc.
$284
Merck Sharp & Dohme LLC
$219
Daiichi Sankyo Inc.
$203
BeiGene USA, Inc.
$185
GlaxoSmithKline, LLC.
$166
Astellas Pharma US Inc
$166
E.R. Squibb & Sons, L.L.C.
$156
ABBVIE INC.
$155
Incyte Corporation
$132
Regeneron Healthcare Solutions, Inc.
$126
Genmab U.S., Inc.
$119
Eisai Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$107
Celgene Corporation
$107
Gilead Sciences, Inc.
$96
Dendreon Pharmaceuticals LLC
$70
PharmaEssentia USA Corporation
$69
PUMA BIOTECHNOLOGY, INC.
$68
Karyopharm Therapeutics Inc.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Bayer Healthcare Pharmaceuticals Inc.
$49
Stemline Therapeutics Inc.
$49
Lilly USA, LLC
$46
Genentech USA, Inc.
$46
RECORDATI_RARE_DISEASES_INC.
$43
Ipsen Biopharmaceuticals, Inc
$40
EMD Serono, Inc.
$40
SOBI, INC
$36
Rigel Pharmaceuticals, Inc.
$34
Blueprint Medicines Corporation
$32
ARRAY BIOPHARMA INC
$28
Deciphera Pharmaceuticals Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Aveo Pharmaceuticals, Inc.
$23
Kite Pharma, Inc.
$22
SpringWorks Therapeutics, Inc.
$22
GENZYME CORPORATION
$21
Alexion Pharmaceuticals, Inc.
$17
CSL Behring
$15
Mirati Therapeutics, Inc.
$14
Sumitomo Pharma America, Inc.
$13
Top 3 companies account for 22.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,148
AstraZeneca Pharmaceuticals LP
$1,688
Janssen Biotech, Inc.
$1,499
E.R. Squibb & Sons, L.L.C.
$1,349
PFIZER INC.
$1,063
Amgen Inc.
$935
Merck Sharp & Dohme Corporation
$838
Merck Sharp & Dohme LLC
$771
Incyte Corporation
$720
Genentech USA, Inc.
$660
Astellas Pharma US Inc
$600
Celgene Corporation
$578
Seagen Inc.
$575
GlaxoSmithKline, LLC.
$537
GENZYME CORPORATION
$533
BeiGene USA, Inc.
$516
Takeda Pharmaceuticals U.S.A., Inc.
$461
Pharmacyclics LLC, An AbbVie Company
$461
Daiichi Sankyo Inc.
$446
Regeneron Healthcare Solutions, Inc.
$423
Karyopharm Therapeutics Inc.
$411
Coherus Biosciences Inc.
$355
Gilead Sciences, Inc.
$346
Lilly USA, LLC
$314
Boehringer Ingelheim Pharmaceuticals, Inc.
$312
Ipsen Biopharmaceuticals, Inc
$282
Rigel Pharmaceuticals, Inc.
$279
Dendreon Pharmaceuticals LLC
$273
EMD Serono, Inc.
$245
Bayer HealthCare Pharmaceuticals Inc.
$244
Puma Biotechnology, Inc.
$237
Foundation Medicine, Inc.
$231
EISAI INC.
$227
Eisai Inc.
$223
ABBVIE INC.
$218
Blueprint Medicines Corporation
$208
Teva Pharmaceuticals USA, Inc.
$193
AbbVie Inc.
$179
Kite Pharma, Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$158
Ethicon Inc.
$147
PUMA BIOTECHNOLOGY, INC.
$145
SOBI, INC
$140
AMAG Pharmaceuticals, Inc.
$140
ARRAY BIOPHARMA INC
$138
Pharmacyclics LLC, an AbbVie Company
$137
Aurobindo Pharma USA, Inc.
$135
Alexion Pharmaceuticals, Inc.
$131
TerSera Therapeutics LLC
$123
AbbVie, Inc.
$122
Genmab U.S., Inc.
$119
MorphoSys, US Inc.
$118
Stemline Therapeutics Inc.
$118
Seattle Genetics, Inc.
$112
CSL Behring
$111
AVEO Pharmaceuticals, Inc.
$110
Dova Pharmaceuticals
$104
Octapharma USA, Inc.
$92
Taiho Oncology, Inc.
$83
TESARO, Inc.
$76
Deciphera Pharmaceuticals Inc.
$76
Epizyme, Inc.,
$76
Mirati Therapeutics, Inc.
$75
Spectrum Pharmaceuticals Inc.
$73
Clovis Oncology, Inc.
$73
Verity Pharmaceuticals Inc.
$72
Sobi, Inc
$70
PharmaEssentia USA Corporation
$69
Agios Pharmaceuticals, Inc.
$68
Secura Bio, Inc.
$67
Acceleron Pharma, Inc.
$66
Heron Therapeutics, Inc.
$65
RECORDATI_RARE_DISEASES_INC.
$64
Sumitomo Pharma America, Inc.
$63
Lexicon Pharmaceuticals, Inc.
$61
TG THERAPEUTICS, INC.
$57
Sun Pharmaceutical Industries Inc.
$56
Helsinn Therapeutics (U.S.), Inc.
$53
Adaptive Biotechnologies Corporation
$52
Alnylam Pharmaceuticals Inc.
$49
Pharmacosmos Therapeutics Inc.
$48
Array BioPharma Inc.
$48
TOLMAR Pharmaceuticals, Inc.
$39
Jazz Pharmaceuticals Inc.
$39
EUSA Pharma (US) LLC
$34
Acrotech Biopharma LLC
$32
APO-PHARMA USA, INC.
$31
JAZZ PHARMACEUTICALS INC.
$31
Janssen Pharmaceuticals, Inc
$30
ImmunoGen, Inc.
$28
CTI BioPharma Corp.
$26
Chiesi USA, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Sirtex Medical Inc
$25
G1 Therapeutics, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Progenics Pharmaceuticals, Inc.
$23
Myovant Sciences Inc.
$23
Aveo Pharmaceuticals, Inc.
$23
GE HealthCare
$22
Novo Nordisk Inc
$22
SpringWorks Therapeutics, Inc.
$22
Exelixis Inc.
$19
Partner Therapeutics, Inc.
$18
MEDIVATION FIELD SOLUTIONS LLC
$18
SANOFI-AVENTIS U.S. LLC
$17
Kyowa Kirin, Inc.
$16
West Therapeutics Development, LLC
$16
Myriad Genetic Laboratories, Inc.
$15
Novocure Inc.
$14
CHIESI USA, INC.
$13
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Creon · DARZALEX · DEFERIPRONE · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FARYDAK · FASLODEX · FERAHEME · FERRIPROX · FERRIPROX 500ML BOTTLE · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lonsurf · Lunsumio · MAVYRET · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYLOTARG · Monarch Platform · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Novoeight · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RUXIENCE · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
17
Per 100K population
0.7
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Law is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Law experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Law performed 145,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Law receive payments from pharmaceutical companies?
Yes. Dr. Law received a total of $26,394 from 111 companies across 1,407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Law's costs compare to other hematology & oncology specialists in Rancho Mirage?
Dr. Law's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Law) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rancho Mirage
Browse hematology & oncology specialists in Rancho Mirage ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology